Free Trial

Charles River Laboratories International (CRL) Competitors

Charles River Laboratories International logo
$151.95 +0.84 (+0.56%)
Closing price 06/12/2025 03:59 PM Eastern
Extended Trading
$149.62 -2.33 (-1.53%)
As of 09:28 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CRL vs. MTD, WAT, ILMN, TECH, BIO, BRKR, PACB, HBIO, TMO, and A

Should you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry.

Charles River Laboratories International vs. Its Competitors

Mettler-Toledo International (NYSE:MTD) and Charles River Laboratories International (NYSE:CRL) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, community ranking, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

Mettler-Toledo International has a net margin of 22.29% compared to Charles River Laboratories International's net margin of 0.52%. Charles River Laboratories International's return on equity of 14.69% beat Mettler-Toledo International's return on equity.

Company Net Margins Return on Equity Return on Assets
Mettler-Toledo International22.29% -591.54% 26.78%
Charles River Laboratories International 0.52%14.69%6.79%

95.1% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are owned by institutional investors. 1.9% of Mettler-Toledo International shares are owned by insiders. Comparatively, 1.3% of Charles River Laboratories International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Mettler-Toledo International presently has a consensus price target of $1,302.11, indicating a potential upside of 9.37%. Charles River Laboratories International has a consensus price target of $171.85, indicating a potential upside of 13.09%. Given Charles River Laboratories International's higher probable upside, analysts clearly believe Charles River Laboratories International is more favorable than Mettler-Toledo International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mettler-Toledo International
0 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.40
Charles River Laboratories International
1 Sell rating(s)
12 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.18

In the previous week, Mettler-Toledo International and Mettler-Toledo International both had 10 articles in the media. Mettler-Toledo International's average media sentiment score of 1.46 beat Charles River Laboratories International's score of 0.60 indicating that Mettler-Toledo International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mettler-Toledo International
9 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Charles River Laboratories International
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Mettler-Toledo International has higher earnings, but lower revenue than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mettler-Toledo International$3.83B6.46$863.14M$40.1029.69
Charles River Laboratories International$4.02B1.86$474.62M-$0.65-233.77

Mettler-Toledo International has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500. Comparatively, Charles River Laboratories International has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500.

Charles River Laboratories International received 124 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 59.52% of users gave Charles River Laboratories International an outperform vote while only 56.26% of users gave Mettler-Toledo International an outperform vote.

CompanyUnderperformOutperform
Mettler-Toledo InternationalOutperform Votes
373
56.26%
Underperform Votes
290
43.74%
Charles River Laboratories InternationalOutperform Votes
497
59.52%
Underperform Votes
338
40.48%

Summary

Mettler-Toledo International and Charles River Laboratories International tied by winning 8 of the 16 factors compared between the two stocks.

Get Charles River Laboratories International News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRL vs. The Competition

MetricCharles River Laboratories InternationalCommercial physical research IndustryMedical SectorNYSE Exchange
Market Cap$7.46B$3.36B$5.61B$19.88B
Dividend YieldN/A2.05%5.28%3.82%
P/E Ratio1,013.00122.3027.1435.60
Price / Sales1.86166.21414.3043.81
Price / Cash7.4834.5738.2517.51
Price / Book2.242.577.074.85
Net Income$474.62M$118.81M$3.23B$1.02B
7 Day Performance4.99%1.92%0.71%0.90%
1 Month Performance5.24%9.03%9.65%2.35%
1 Year Performance-28.47%-20.15%32.07%10.79%

Charles River Laboratories International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRL
Charles River Laboratories International
4.702 of 5 stars
$151.95
+0.6%
$171.85
+13.1%
-28.9%$7.46B$4.02B1,013.0021,400
MTD
Mettler-Toledo International
3.743 of 5 stars
$1,196.53
+1.0%
$1,302.11
+8.8%
-18.4%$24.87B$3.83B29.5218,000Positive News
WAT
Waters
4.1775 of 5 stars
$348.56
-0.7%
$390.19
+11.9%
+16.0%$20.74B$2.98B32.558,200
ILMN
Illumina
4.8983 of 5 stars
$84.98
+2.8%
$128.84
+51.6%
-18.8%$13.45B$4.34B-11.0711,500Positive News
Analyst Forecast
Options Volume
TECH
Bio-Techne
4.874 of 5 stars
$49.88
+2.4%
$72.00
+44.3%
-33.5%$7.82B$1.21B50.383,000Positive News
BIO
Bio-Rad Laboratories
4.7767 of 5 stars
$225.84
+2.9%
$324.25
+43.6%
-18.0%$6.15B$2.54B-3.478,200Analyst Revision
BRKR
Bruker
4.9612 of 5 stars
$39.21
+2.4%
$56.22
+43.4%
-39.8%$5.94B$3.45B51.598,520
PACB
Pacific Biosciences of California
2.2371 of 5 stars
$1.20
+5.3%
$2.13
+77.6%
-40.4%$360.10M$152.36M-0.73730Positive News
HBIO
Harvard Bioscience
3.9211 of 5 stars
$0.56
+36.5%
$3.00
+437.3%
-82.4%$24.69M$91.40M-1.69490Trending News
Short Interest ↑
High Trading Volume
TMO
Thermo Fisher Scientific
4.9763 of 5 stars
$408.57
+1.7%
$605.30
+48.2%
-27.9%$154.23B$42.90B24.72130,000Positive News
A
Agilent Technologies
4.6222 of 5 stars
$116.77
+0.8%
$140.15
+20.0%
-10.7%$33.17B$6.51B28.8317,900

Related Companies and Tools


This page (NYSE:CRL) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners